| 摘要 |
<p>A method for identifying individuals with a propensity for fibrotic scarring. The method involves providing a sample from an individual with a chronic inflammatory disease, contacting the sample with an antibody specific for fibroblast stimulating factor-1 (FSF-1) under conditions which permit immunocomplex formation, and detecting an increase in the relative level of the immunocomplex as an indication of a propensity for fibrotic scarring. FSF-1 polypeptides and antibodies specific for FSF-1 are also disclosed.</p> |
